Sakuma, Shinji published the artcileEffect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal, Synthetic Route of 38260-01-4, the publication is Journal of Controlled Release (2007), 118(1), 59-64, database is CAplus and MEDLINE.
Food-drug interactions may reduce the bioavailability of drugs taken after meals (neg. food effect). In order to develop pharmaceutical technologies that overcome this problem, the effect of administration site within the gastrointestinal tract on the bioavailability of several model drugs was examined in rats. Bioavailability after oral administration to fed animals was one-fifth to one-tenth of that in the fasted animals because of interactions between drugs and large amounts of food components remaining in the stomach. This strong neg. food effect was reduced when drugs were administered directly into any site of the small intestine. Bioavailability was maximized when the drug administration site was the middle small intestine. On the other hand, intracolonic administration did not result in the reduction of the neg. food effect. Site-specific drug delivery to the middle small intestine could be a useful approach for reducing the neg. food effect on drug absorption with maximized bioavailability.
Journal of Controlled Release published new progress about 38260-01-4. 38260-01-4 belongs to catalysis-chemistry, auxiliary class Chelating Agents, name is N1,N1′-(Ethane-1,2-diyl)bis(ethane-1,2-diamine) dihydrochloride, and the molecular formula is C6H20Cl2N4, Synthetic Route of 38260-01-4.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia